ReviewDrug design, development and therapy2013
An early indicator of drug success: Top Journal Selectivity Index.
Review in Drug design, development and therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- 4-nitrobenzoate inhibits 4-hydroxybenzoate polyprenyltransferase in malaria parasites and enhances atovaquone efficacy.FEBS letters · 2026Article
- Palmatine, a Bioactive Protoberberine Alkaloid Isolated fromMolecules (Basel, Switzerland) · 2021Article
- Antiplasmodial and Cytotoxic Activities of Extracts of Selected Medicinal Plants Used to Treat Malaria in Embu County, Kenya.Journal of parasitology research · 2020Article
- Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis.International journal of environmental research and public health · 2019Article
- A quest to increase safety of anesthetics by advancements in anesthesia monitoring: scientometric analysis.Drug design, development and therapy · 2015Review
- Scientometrics of drug discovery efforts: pain-related molecular targets.Drug design, development and therapy · 2015Article
- Scientometrics of anesthetic drugs and their techniques of administration, 1984-2013.Drug design, development and therapy · 2014Article
- Scientometric assessment of drugs for chronic pain, 1979-2013: rapid growth of publications, paucity of successful drugs.Journal of pain research · 2014Article
- No evidence of real progress in treatment of acute pain, 1993-2012: scientometric analysis.Journal of pain research · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Top Journal Selectivity Index (TJSI) is a scientometric index reflecting the potential importance of a new drug. It represents the ratio of the number of all types of articles on a particular drug in the top 20 journals relative to the number of articles in all (>5,000) biomedical journals covered by Medline over the 5 years since the drug's introduction. The TJSI can be an indicator of a drug's potential for sustained use: a higher score increases the probability of continuing success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.